OMNI Life Science Competitors and Similar CompaniesClear all

OMNI Life Science's competitors and similar companies include Telo Genomics, Wax-it, C-RAD and Transmural Biotech.

	OMNI Life Science OMNI Life Science is a provider of clinical research and healthcare technology services.	Telo Genomics Telo Genomics is a biotechnology company that provides technological products.	Wax-it Wax-it is a contract research company.	C-RAD C-RAD is a company that develops surface scanning systems and technologies for precision in cancer radiotherapy.	Transmural Biotech Transmural Biotech is a company that develops medical and healthcare software platform technologies.
Founding Date	Founding Date 2004	Founding Date 2014	Founding Date 1994	Founding Date 2004	Founding Date 2009
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare clinical research discovery platform healthtech imaging medical imaging oncology	Tags Healthcare biotech clinical research healthtech medical diagnostics medical imaging oncology	Tags Healthcare clinical research medical imaging oncology	Tags Healthcare medical devices medical imaging medtech	Tags Healthcare application software discovery platform healthtech imaging medical devices medical imaging
Locations	Locations Bremen, DE HQ	Locations HQ	Locations Vancouver, CA HQ	Locations Uppsala, SE HQ Paris, FR Berlin, DE Uppsala, SE Delray Beach, US	Locations Barcelona, ES HQ
Employees	Employees 303% decrease	Employees N/A	Employees 20	Employees 9914% increase	Employees 12
Valuation ($)	Valuation ($) N/A	Valuation ($) 7.5 m	Valuation ($) N/A	Valuation ($) 95.6 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr441.9m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods kr135.9m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit kr306.6m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($2.7m) (FY, 2025)	Net income N/A	Net income kr10.5m (FY, 2025)	Net income N/A